Doctaverse

Illness Anxiety Disorder in Children: DSM-5 Diagnostic Monograph

Clinician reference on pediatric illness anxiety disorder (health anxiety) — DSM-5 criteria, care-seeking vs care-avoidant types, red flags, and a reassurance-limiting management overview.

Full criteria: Illness Anxiety Disorder.

Definition and DSM-5 criteria

Illness anxiety disorder (IAD) — historically “hypochondriasis” — is preoccupation with having or acquiring a serious illness in the near-absence of somatic symptoms. The defining contrast with somatic symptom disorder is the symptom burden: in IAD bodily symptoms are absent or mild, and the distress is driven by the fear of illness rather than by the symptoms themselves. About a quarter of patients formerly labelled hypochondriacal map to IAD; the remainder, who have prominent somatic symptoms, map to SSD.

The DSM-5 criteria are:

Specify type: care-seeking or care-avoidant.

Clinical features

In adolescents IAD presents as repeated reassurance-seeking, frequent internet symptom-searching (“cyberchondria”), body-checking, and either heavy or pointedly avoided medical contact. A child may fixate on a feared diagnosis after a relative’s illness or a media story. Normal physiological sensations — a heartbeat, a swollen lymph node — are catastrophically misinterpreted. Reassurance helps only transiently, then the cycle resumes. Comorbid anxiety, depression and OCD are common.

Diagnosis

IAD is a positive diagnosis made on the pattern of disproportionate illness fear with minimal somatic symptoms, sustained ≥6 months. Distinguish it from SSD (prominent somatic symptoms), generalized anxiety disorder (broader worry), panic disorder (acute episodic fear), and OCD/body dysmorphic disorder. A focused, time-limited work-up excludes serious disease, but repeated investigation is itself reinforcing and should be limited.

See the full criteria: Illness Anxiety Disorder

Red flags

Management overview

Begin by validating the distress — the fear is real and exhausting — while gently reframing the problem as one of anxiety about health rather than undiagnosed disease. Avoid the two common errors: endless reassurance and repeat testing (which entrench the cycle) and dismissiveness (which ruptures trust). Set a single coordinating clinician and scheduled, time-based reviews rather than symptom-triggered visits.

The evidence-based core is cognitive-behavioural therapy targeting catastrophic misinterpretation, reassurance-seeking and body-checking, with graded exposure and response prevention. Psychoeducation, limiting symptom-searching, and family involvement (parental modelling matters) are central. Treat comorbid anxiety or depression; an SSRI may be considered by a child mental-health specialist where comorbidity warrants it. Coordinate firmly but compassionately to reduce iatrogenic harm from over-investigation.

References

  1. American Psychiatric Association. DSM-5-TR. 2022.
  2. MSD Manual Professional. Illness Anxiety Disorder. 2024.
  3. Axelsson E, Hedman-Lagerlof E. Health anxiety. Curr Opin Psychiatry. 2019.

Decision support for qualified clinicians only — verify against current primary guidelines and your clinical judgement.

Get the Doctaverse app

Use the calculators, diagnostic criteria and drug formulary at the bedside.

Google Play App Store Run the diagnostic

References

Last updated 2026-06-28.

More like this

Abdominal Migraine in Children: A Clinician's Monograph

Clinician reference on pediatric abdominal migraine — Rome IV criteria, the stereotyped paroxysmal pattern, red flags that mandate workup, and management.

Allergic Bronchopulmonary Aspergillosis: A Clinician's Monograph

Clinician reference on ABPA in children — ISHAM/Rosenberg-Patterson criteria, the asthma and cystic fibrosis context, red flags, staging and corticosteroid plus antifungal management.

Allergic Rhinitis in Children: A Clinician's Monograph

Clinician reference on pediatric allergic rhinitis — ARIA intermittent vs persistent and mild vs moderate-severe classification, diagnosis, red flags, and stepwise management.

Anaphylaxis in Children: An A-Z Clinical Monograph

Recognise and treat paediatric anaphylaxis — WAO/EAACI diagnostic criteria, red flags, and first-line IM adrenaline 0.01 mg/kg (max 0.3 mg in children), repeated every 5 minutes.